Physician profile
Anwarullah Mohammed
NPI 1295021764
$286.36
in general payments reported to CMS, 2019-2025
11 companies · $25.17 in 2025
The $25.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $24.91 · 2021: $24.88 · 2022: $26.28 · 2023: $46.85 · 2025: $25.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.40 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.40 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $74.81 | 2019 | |
| Abbott Laboratories | $27.23 | 2023 | Aveir |
| Gilead Sciences, INC. | $26.28 | 2022 | |
| Abbvie INC. | $25.17 | 2025 | |
| Alkermes, INC. | $24.91 | 2020 | |
| Lilly USA, LLC | $24.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.30 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.75 | 2019 | |
| Pfizer INC. | $13.61 | 2019 | |
| Melinta Therapeutics, LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anwarullah Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.